For many years Neisseria meningitidis has been the most common cause of meningitis and septicemia in children and youths in Norway, with a mortality rate above 10% (2). During the period 1974 to 1986, the yearly incidence of meningococcal disease varied between 6.7 per 100,000 inhabitants (1977) and 8.1 per 100,000 inhabitants (1975) . An intriguing question is why colonization of the nasopharynx with meningococci leads to the formation of protective antibodies in some people (10; I. Nessioy, student diploma, University of Tromso, Tromso, Norway, 1983 ) while others may develop systemic disease. To understand the pathogenicity and epidemiology of meningococcal disease, it is necessary to characterize carrier strains phenotypically and genomically, to study their distribution in the normal population, and to know the immunity against meningococcal disease in different population groups. Most studies on the carriage of meningococci have been performed on selected population groups such as soldiers and contacts of cases with meningococcal disease, or the material has been collected over several years (6, 8, 13, 14) .
The aim of the present investigation was to study the meningococcal carrier rate and the levels of antimeningococcal immunoglobulin G (IgG) antibodies in a healthy population, to characterize the carrier isolates by serogrouping, serotyping, and sulfonamide susceptibility testing, and finally to determine the frequency of the predominant disease-associated strain of meningococci in a healthy population in Norway by DNA fingerprinting of chromosomal DNA (1, [15] [16] [17] [18] 1984 , all of them before 20 April. Samples from children and youths were collected at six welfare centers, nine schools, and nine day care centers evenly distributed throughout the community. Samples from adults were collected at various places of work, at the hospital out-patient clinic, at the office of a general practitioner, and at a day care center for the elderly. Table 1 shows the number of males and females sampled in nine different age groups.
Blood samples. Capillary blood was collected by puncture of the fingertip with an automatic lancet (Autolet; Owen Mumford, Woodstock, England). Serum was obtained by immediate centrifugation of the blood at 6,000 x g in small tubes with a barrier material in the bottom (Microtainer system; Becton Dickinson, Rutherford, N.J.). The sera were kept frozen at -22°C.
Throat cultures. Throat samples were obtained from the tonsils and posterior pharynx with a charcoal-impregnated swab and plated immediately on GC agar base supplemented with hemin and IsoVitaleX (BBL Microbiology Systems, Cockeysville, Md.) and containing colistin and vancomycin. The plates were incubated as described previously (17) . Meningococci weré identified by conventional procedures (19 Female  47  89  67  87  81  51  34  48  52  556  Male  57  66  61  105  79  42  36  38  62  546 Serotyping. Serotyping was performed as described previously (18) Sulfonamide susceptibility testing. MICs of sulfadiazine were determined by the agar dilution method (3, 18) . Isolates for which MICs were 5 ,ug/ml or lower were considered sulfonamide susceptible, and those for which MICs were 100 ,u.g/ml or higher were considered resistant. Isolates for which MICs were between S and 100 ,ug/ml were scored as intermediate.
DNA fingerprinting. DNA fingerprinting of chromosomal DNA was performed as described previously (18 (Fig. 3) . Very low levels were present at ages below 12 years but then the levels started to increase and increased steadily until the oldest age studied. Above 20 years of age, the levels of antimeningococcal IgG antibodies were significantly higher in males than in females (P < 0.001, Wilcoxon nonparametric two-sample test). No clearcut correlation was observed Figure 4 shows that the incidence was highest in the youngest age group, where the level of antimeningococcal IgG antibodies was lowest. DISCUSSION In the present study specimens were collected during a 2-month period. Even though the disease is endemic in North Norway, no cases of meningococcal disease occurred within a month of the sampling period. In our study, we found an overall meningococcal carrier rate of 9.8% in the general population. In previous studies in Norway, carrier rates of 43.4% in military recruits (13) and of 39.0% in a semi-isolated population (coal miners and their families) were found 3 weeks after a case of meningococcal disease occurred (14) . The lower carrier rate in our study is probably due to differences in the populations studied, because it has been shown that military recruits and contacts of cases with meningococcal disease have a higher meningococcal carrier rate than the general population (5, 21). In both sexes (Fig. 1 ), the carrier rates were highest between 15 and 39 years of age, which agrees with previous studies (8, 9). The carrier rate was significantly higher in males than in females in the group aged from 20 to 29 years. The explanation of this difference may be that women at this age tend to stay at home with their children and have fewer social contacts than their menfolk and that many males in this age group have recently left the military, where the carrier rate is much higher than among civilians.
Systemic isolates from Norway are phenotypically very homogeneous, more than 80% of them being sulfonamide resistant, serogroup B, and serotype 15 and belonging to a group of genetically related clones (3, 5, 16). In the present study, we show that carrier isolates are phenotypically heterogeneous. In agreement with other studies (6, 7), the carrier isolates were predominantly nongroupable (45.4%) or nontypable (63.0%). In contrast to systemic isolates, relatively few (19.4%) of the carrier isolates were sulfonamide resistant. Sulfonamide resistance was concentrated in isolates of serotype 2a (9 of 9) and serotype 15 (8 of 31). Among the systemic isolates, however, 98% of the serotype 15 isolates were sulfonamide resistant (3).
DNA fingerprint analysis showed that eight (7.4%) of the carrier isolates had a DNA fingerprint similar to that of the epidemic strain in Norway, represented in our study by isolate 035. All eight isolates were sulfonamide resistant, 
